MARK SHEPTOFF FINANCIAL PLANNING, LLC Revance Therapeutics, Inc. Transaction History

MARK SHEPTOFF FINANCIAL PLANNING, LLC portfolio value:

$54,000
portfolio value

Revance Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase 0.00% 2K shares 54K $27 2K